Are you Dr. Crothers?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Walter Reed Army Medical Center
6900 Georgia Avenue Nw
Washington, DC 20307Phone+1 202-782-3223Fax+1 202-782-3217
Summary
- Dr. Barbara Crothers, DO is a board certified pathologist in Washington, District of Columbia. She is currently licensed to practice medicine in Maryland, Virginia, and Tennessee.
Education & Training
- Madigan Army Medical CenterResidency, Pathology-Anatomic and Clinical, 1987 - 1991
- Fitzsimons Army Medical CenterInternship, Transitional Year, 1986 - 1987
- Philadelphia College of Osteopathic MedicineClass of 1986
Certifications & Licensure
- MD State License 2017 - 2026
- PA State License 1988 - 2026
- TN State License 1998 - 2026
- UT State License 1998 - 2026
- VA State License 2017 - 2026
- WV State License 1996 - 2019
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
- National Board of Physicians and Surgeons Cytopathology
- National Board of Physicians and Surgeons Pathology Anatomic and Clinical
Publications & Presentations
PubMed
- Cytologic-Histologic Correlation Practices for Nongynecologic Cytology Specimens: A Survey by the College of American Pathologists Cytopathology Committee.Lananh N Nguyen, Barbara A Crothers, Rhona J Souers, Güliz A Barkan, Jennifer Brainard
Archives of Pathology & Laboratory Medicine. 2024-08-01 - Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.Nicholas W Bateman, Tamara Abulez, Anthony R Soltis, Andrew McPherson, Seongmin Choi
NPJ Precision Oncology. 2024-05-06 - 2 citationsProteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities.Nicholas W Bateman, Tamara Abulez, Anthony R Soltis, Andrew McPherson, Seongmin Choi
NPJ Precision Oncology. 2024-03-13
Professional Memberships
- Member